Senti Biosciences Holdings (SNTI) Income from Non-Controlling Interests (2022 - 2025)

Senti Biosciences Holdings' Income from Non-Controlling Interests history runs 4 years deep, the most recent figure standing at $1.6 million for Q2 2025.

• In Q2 2025, Income from Non-Controlling Interests rose 0.82% year-over-year to $1.6 million; the TTM figure through Jun 2025 stood at $9.7 million (up 218.67% YoY), while the FY2025 annual figure was $5.4 million, down 15.62% from the prior year.
• Income from Non-Controlling Interests for Q2 2025 stood at $1.6 million, down from $1.7 million in the prior quarter.
• The five-year high for Income from Non-Controlling Interests was $6.4 million in Q4 2024, with the low at -$3000.0 in Q2 2023.
• The 4-year median for Income from Non-Controlling Interests is $1.5 million (2024), against an average of $1.6 million.
• The sharpest annual moves came in 2024 and 2025: Income from Non-Controlling Interests soared 72950.0% in 2024, then advanced 0.82% in 2025.
• Senti Biosciences Holdings' Income from Non-Controlling Interests stood at $1000.0 in 2022, then plunged by 400.0% to -$3000.0 in 2023, then jumped by 213433.33% to $6.4 million in 2024, then slumped by 75.0% to $1.6 million in 2025.
• Business Quant data shows SNTI's Income from Non-Controlling Interests at $1.6 million in Q2 2025, $1.7 million in Q1 2025, and $6.4 million in Q4 2024.